Eaton Vance Management’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$849K Sell
6,029
-11
-0.2% -$2.01K ﹤0.01% 1257
2022
Q2
$1.23M Sell
6,040
-241
-4% -$52.8K ﹤0.01% 1211
2022
Q1
$1.6M Sell
6,281
-80
-1% -$21.7K ﹤0.01% 1247
2021
Q4
$2.09M Buy
6,361
+67
+1% +$21K ﹤0.01% 1012
2021
Q3
$1.82M Buy
6,294
+1,988
+46% +$565K ﹤0.01% 954
2021
Q2
$1.17M Buy
4,306
+272
+7% +$69K ﹤0.01% 1137
2021
Q1
$983K Hold
4,034
﹤0.01% 1139
2020
Q4
$1.16M Buy
+4,034
New +$1.11M ﹤0.01% 1047

Other funds holding MLAB

Eaton Vance Management's MLAB Position: Q3 2022 in Review

Eaton Vance Management reduced its Mesa Laboratories (MLAB) stake by 0.18% in Q3 2022, selling an estimated $2.01K and leaving 6,029 shares worth $849K. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

Eaton Vance Management first reported a position in MLAB in Q4 2020 and has held it in 8 quarters since. The position peaked at $2.09M in Q4 2021. 163 funds tracked by Wall St. Rank hold MLAB as of Q3 2022.

  • Eaton Vance Management held 6,029 shares of Mesa Laboratories worth $849K as of Q3 2022.
  • Eaton Vance Management sold 11 Mesa Laboratories shares in Q3 2022, an estimated $2.01K.
  • Mesa Laboratories made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #1257 holding.
  • Eaton Vance Management first reported a position in Mesa Laboratories in Q4 2020 and has held it in 8 quarters since.
  • Eaton Vance Management's Mesa Laboratories position peaked at $2.09M in Q4 2021.
  • 163 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.